Loading…
iSpecimen Inc. is projected to decline to $2.98 by 2027, a -11% move from its current price of $3.35. ISPC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.15 | $3.35 | $3.56 | +0.09% |
| May 30 | $3.08 | $3.36 | $3.66 | +0.19% |
| May 31 | $3.02 | $3.36 | $3.73 | +0.28% |
| Jun 1 | $2.98 | $3.36 | $3.80 | +0.37% |
| Jun 2 | $2.94 | $3.37 | $3.86 | +0.46% |
| Jun 3 | $2.90 | $3.37 | $3.91 | +0.56% |
| Jun 4 | $2.87 | $3.37 | $3.96 | +0.65% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.87 | $3.37 | $3.96 | +0.65% |
| Week 2 | $2.70 | $3.39 | $4.26 | +1.31% |
| Week 3 | $2.58 | $3.42 | $4.52 | +1.97% |
| Week 4 | $2.49 | $3.44 | $4.75 | +2.63% |
| Week 5 | $2.41 | $3.46 | $4.96 | +3.30% |
| Week 6 | $2.35 | $3.48 | $5.17 | +3.97% |
| Week 7 | $2.29 | $3.51 | $5.37 | +4.65% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
iSpecimen Inc. operates a marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them.
The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types.
It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.
iSpecimen Inc. (ISPC) currently trades around $3.45 per share, with a market cap of $4.96M, and holds a market position described by a rank of 5345.
The current price and market position are joined by a year-by-year forecast that shows a path from neutral in the near term to bullish in the longer term. By 2050 the forecast envisions a max price of $26.62 and an average of $11.57, implying a potential ROI of 235.4% in 2050.
In the nearer horizon, 2029 is forecast to produce an average of $5.03 with a max of $8.44 and a 45.9% ROI, while 2030 shows an average of $4.59 with a max of $8.00 and a 33% ROI.
A major floor 62.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 93.4% above — a clean break opens room to run.
A major ceiling 359.7% above — clearing it would confirm fresh momentum.
Key ISPC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ISPC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.43 | Sell | $3.49 | Sell |
| MA 10 | $3.71 | Sell | $3.77 | Sell |
| MA 20 | $4.47 | Sell | $4.27 | Sell |
| MA 50 | $5.35 | Sell | $5.88 | Sell |
| MA 100 | $8.76 | Sell | $10.07 | Sell |
| MA 200 | $20.97 | Sell | $24.98 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.38 | Neutral |
| Stoch RSI (14) | 5.17 | Buy |
| CCI (20) | -95.60 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | -34.57 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.50 | Sell |
| Awesome (5,34) | -1.32 | Sell |
| Ultimate (7,14,28) | 17.84 | Buy |
| Momentum (10) | -1.19 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 3.28 | Buy |
| ADX (14) | 23.71 | Sell |
| ATR (14) | 0.29 | Info |
The 30-day technical picture is BEARISH.
RSI(14) is 30, with a 50-day smoother view indicated by a SMA50 of $5.60 and a SMA200 of $21.55. The near-term price framework includes a support level at $3.40 and a resistance at $6.48.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.35 | $3.35 | $4.24 | 0% | Neutral | |
| $2.14 | $2.98 | $4.48 | -11% | Neutral | |
| $2.63 | $3.88 | $6.21 | +16% | Neutral | |
| $3.19 | $4.95 | $8.29 | +48% | Bullish | |
| $2.72 | $4.42 | $7.71 | +32% | Bullish | |
| $2.51 | $4.27 | $7.70 | +27% | Bullish | |
| $2.44 | $4.32 | $8.03 | +29% | Bullish | |
| $1.92 | $3.54 | $6.76 | +6% | Neutral | |
| $2.23 | $4.29 | $8.39 | +28% | Bullish | |
| $2.76 | $5.51 | $11.04 | +65% | Bullish | |
| $2.66 | $5.91 | $12.99 | +76% | Bullish | |
| $5.14 | $11.41 | $26.25 | +241% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.35 | $3.35 | $3.95 | +0.00% |
| June 2026 | $2.78 | $3.34 | $4.15 | -0.43% |
| July 2026 | $2.99 | $3.65 | $4.65 | +9.29% |
| August 2026 | $2.97 | $3.68 | $4.78 | +0.85% |
| September 2026 | $2.73 | $3.42 | $4.51 | -7.07% |
| October 2026 | $2.68 | $3.39 | $4.53 | -0.85% |
| November 2026 | $2.69 | $3.42 | $4.64 | +1.01% |
| December 2026 | $2.41 | $3.09 | $4.24 | -9.63% |
Click any year to see its month-by-month ISPC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ISPC price prediction for 2026 points to an average of $3.35 (low $3.35, high $4.24) — a potential gain of 0% on today's $3.35. Price action looks broadly range-bound.
In 2027, ISPC is projected to trade between $2.14 and $4.48, averaging $2.98 — a potential decline of -11% from today's $3.35. That is -11% versus the projected 2026 average. A consolidation phase looks the most probable path here.
iSpecimen Inc.'s 2028 outlook centres on $3.88, within a $2.63 to $6.21 range. That is up +30% on the projected 2027 average. That marks a +16% change versus current levels. Price action looks broadly range-bound.
By 2029, ISPC could reach as high as $8.29, with a base case around $4.95 and support toward $3.19 — roughly +48% from $3.35. Buyers look set to stay in control over this stretch.
Expect ISPC to range from $2.72 to $7.71 through 2030. The $4.42 average target implies a +32% move from current prices. That is -11% versus the projected 2029 average. Momentum favours further upside here.
The ISPC price prediction for 2031 points to an average of $4.27 (low $2.51, high $7.70) — a potential gain of +27% on today's $3.35. Buyers look set to stay in control over this stretch.
In 2032, ISPC is projected to trade between $2.44 and $8.03, averaging $4.32 — a potential gain of +29% from today's $3.35. That is up +1% on the projected 2031 average. Momentum favours further upside here.
iSpecimen Inc.'s 2033 outlook centres on $3.54, within a $1.92 to $6.76 range. That is -18% versus the projected 2032 average. That marks a +6% change versus current levels. A consolidation phase looks the most probable path here.
By 2034, ISPC could reach as high as $8.39, with a base case around $4.29 and support toward $2.23 — roughly +28% from $3.35. Momentum favours further upside here.
Expect ISPC to range from $2.76 to $11.04 through 2035. The $5.51 average target implies a +65% move from current prices. That is up +29% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The ISPC price prediction for 2040 points to an average of $5.91 (low $2.66, high $12.99) — a potential gain of +76% on today's $3.35. Momentum favours further upside here.
In 2050, ISPC is projected to trade between $5.14 and $26.25, averaging $11.41 — a potential gain of +241% from today's $3.35. That is up +93% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ISPC today (≈ 298.507463 ISPC) could be worth
$3,406.82
+$2,406.82 (+241%) by 2050 · US Dollar
Based on the average projected ISPC price of $11.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ISPCwould be worth at today's price.
$1,000 invested in ISPC on May 27, 2025 (≈ 22.321429 ISPC) would be worth
$74.78
-$925.22 (-92.5%) today · 0.07× · US Dollar
Based on a ISPC entry price of $44.8 vs. today's $3.35.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.4 | $985.29 | -1.5% |
| 1 month ago | $4.92 | $680.89 | -31.9% |
| 3 months ago | $11 | $304.55 | -69.5% |
| 6 months ago | $16.8 | $199.4 | -80.1% |
| 1 year ago | $44.8 | $74.78 | -92.5% |
| All time (4.9y) ago | $5,720 | $0.59 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ISPC forecast.
Our base-case forecast reaches $6.70 around 2050.
Implied market cap at $6.70: $9.63M
Looking further out, the multi-year forecast turns bullish from 2029 onward. The 2029 forecast shows an average of $5.03, a max of $8.44, and a 45.9% ROI, with a BULLISH sentiment.
2030 maintains the bullish trajectory with an average of $4.59 and a max of $8.00, yielding a 33% ROI.
Beyond 2030, 2035 projects an average of $5.66 with a max of $11.34 and a 64.1% ROI, while 2040 shows an average of $6.12, a max of $13.46 and a 77.3% ROI. The model also anticipates continued upside toward 2050, with an average of $11.57, a max of $26.62 and a 235.4% ROI, all in a bullish context.
Tap a question to reveal the answer.
The 2030 forecast shows min $2.82, avg $4.59, max $8.00, ROI 33, sentiment BULLISH.
Forecasts indicate a bullish trajectory from 2029 onward, with 2029 avg $5.03 and max $8.44, 2030 avg $4.59 and max $8.00, and a long-run 2050 max $26.62, avg $11.57 and ROI 235.4%, though earlier years show more modest or negative momentum.
Yes—the 2030 forecast lists a max of $8.00, with an average of $4.59 and a min of $2.82, supported by bullish sentiment for 2030.
Current price is $3.45 and market cap is $4.96M, with a market-rank of 5345.
The 30-day range is $2.25 to $5.29; RSI(14) is 30; sentiment is BEARISH; SMA50 is $5.60; SMA200 is $21.55; support is $3.40 and resistance is $6.48; annualized volatility is 100%.
iSpecimen Inc. Community Discussion
0Share your iSpecimen Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.